Figure 4

Kaplan–Meier survival curve comparing percentage survival in patients who were anti-apoA-1-positive ( n  = 135) and anti-apoA-1-negative ( n =364) in their early disease sample. Time (x axis) measured in years. The number of subjects at risk at each time point was as follows: 499 at time 0, 290 at 10 years, 103 at 20 years and 31 at 30 years. anti-apoA-1, antibodies to apolipoprotein A-1.